Advanced glycation end products (AGEs) are formed in non-enzymatic reaction, oxidation,
rearrangement and cross-linking between the active carbonyl groups of reducing sugars …

AD is a progressive neurodegenerative disorder and a leading cause of dementia in an
aging population worldwide. The enormous challenge which AD possesses to global …

Ethnopharmacological relevance Melissa officinalis L. is a medicinal plant that has long
been used in different ethno-medical systems especially in the European Traditional …

Alzheimer's disease (AD) is a most common neurodegenerative disorder, which associates
with impaired cognition. Gut microbiota can modulate host brain function and behavior via …

Glutamatergic and cholinergic dysfunction are well‐attested features of Alzheimer's disease
(AD), progressing with other pathological indices of the disorder and exacerbating neuronal …

The microbiota-gut-brain axis includes a two-way communication pattern between the
microorganisms that live in our gut and our brain function and behavior. Intestinal flora …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder, in which multiple risk
factors converge. Despite the complexity of the etiology of the disease, synaptic failure is the …

Alzheimer's disease (AD) and related dementias (ADRD) are still a serious global public
health concern more than a century after the German neuropathologist and psychiatrist Dr …

Despite extensive progress in understanding the pathology of Alzheimer's disease (AD) over
the last 50 years, clinical trials based on the amyloid–beta (Aβ) hypothesis have kept failing …

Probiotic intervention has beneficial effects on host brain function and behavior via
regulating microbiota-gut-brain axis; however, the underlying mechanism is not yet …